Literature review of burden of illness and cardiovascular risk group identification of symptomatic peripheral artery disease
Literature review and payer appraisals in peripheral artery disease
Budget impact and economic evaluation of a statin
Advisory board on arterial occlusive disease
Workshop communicating health economic data of an anticoagulant medication for deep vein thrombosis (DVT)
Development of a treatment satisfaction measure for an injectable low-density lipoprotein (LDL) cholesterol lowering medication
Costs for psychometric validation of the Injection-Treatment Acceptance Questionnaire (I-TAQ) in an independent observational study in hypercholesterolemia
Statistical consultancy to support use of the I-TAQ for a cholesterol-lowering medication
Production of a revised heart model for hypercholesterolaemia incorporating additional comments from country affiliates
Worldwide database analysis of statins and cholesterol levels
Probabilistic analysis of a statin model and advice on a pharmacoeconomic manuscript
Endpoint review for FDA-approved flushing claims in atherosclerosis
Payer digital value communication testing in stroke prevention in patients with atrial fibrillation (SPAF)
Analysis of atrial fibrillation in the UK
Qualitative research on PROs in atrial fibrillation
Development of PRO instrument modules and validation research in atrial fibrillation
Manuscript on the development of a symptoms questionnaire in atrial fibrillation
Decentralised framework for real life data generation in stroke prevention in atrial fibrillation (SPAF)
Reporting of development work in atrial fibrillation
Indirect comparison of two drugs used in the prevention of thromboembolic events due to atrial fibrillation
Analysis of the Anti-Clot Treatment Scale (ACTS), Treatment Satisfaction Questionnaire for Medication (TSQM) and healthcare resource utilization in a clinical trial in atrial fibrillation
Manuscript development on the ACTS/TSQM data
Manuscript support for statistical results in an observational study measuring outcomes in atrial fibrillation
Measurement of resource use, satisfaction, productivity and HRQoL in atrial fibrillation
Translation and validation of the ACTS and TSQM in atrial fibrillation in Japan
Strategic treatment pathways for treatment in pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH)
Update to payer value decks in PAH and CTEPH
Framework for real world evidence generation in PAH and CTEPH
Strategic plan and real-world evidence toolkit in PAH and CTEPH
Consultancy on interpretation of phase III trial endpoints in PAH and CTEPH
Meta-analysis, systematic literature review, data extraction and report on an oral combination treatment of PAH
Systematic literature review, data extraction & report on sensitivity analyses and a meta-analysis of an oral combination treatment of PAH
Meta-analysis of an oral combination treatment of PAH
Meta-analysis of an oral treatment of PAH – exploratory analyses on the effect of administering additional PAH-specific therapy upon two additional endpoints
Literature review of pulmonary hypertension secondary to chronic obstructive pulmonary disease (COPD)
Utility assessment in PAH
Literature review of PAH secondary to chronic obstructive pulmonary disease (COPD)
Interpretation of clinical trial results in PAH
Cognitive debriefing interviews with patients with PAH
Network meta-analysis of combination therapies in PAH
Psychometric validation of the Living with Pulmonary Hypertension (LPH) questionnaire in PAH
PRO claims for PAH – endpoint review and regulatory support for the FDA and EMEA
PRO claims for PAH: endpoint review, regulatory support and qualitative patient interviews
Qualitative research to explore patient preference for modes of administration in PAH treatments
Budget impact model for an anti-hypertensive treatment
UK cost offset model of two treatments for hypertension
Preparation of an interactive report on a cost-offset model for a treatment for hypertension
Asian value dossier for hypertension
Heart study economic model in hypertension
Advisory board on hypertension
Cost model for a direct renin inhibitor medication for the treatment of hypertension
Validation of an adherence questionnaire for hypertension patients utilizing administrative data
Hypertension database analysis in Japan
Data management and reporting on a cardiovascular health outcomes project switching study in hypertension
Development of a compliance and persistence screener in hypertensive patients at risk for cardiovascular events
Validation of data analysis with an FDA response in orthostatic hypertension
Adaptation of a heart study economic model in hypertension to Korea
Validation of the hypertension / dyslipidaemia treatment satisfaction survey
Hypotension
Defence of the use of the Orthostatic Hypotension Questionnaire (OHQ) to demonstrate treatment benefit and labelling claim in neurogenic orthostatic hypotension
Validation of the OHQ in neurogenic orthostatic hypotension using clinical trial data
Key opinion leader interviews on neurogenic orthostatic hypotension
Evaluation of the current measurement strategy in neurogenic orthostatic hypotension
Defence of the use of the Orthostatic Hypotension Questionnaire (OHQ) to demonstrate treatment benefit and labelling claim in neurogenic orthostatic hypotension
Validation of the OHQ in neurogenic orthostatic hypotension using clinical trial data
Key opinion leader interviews on neurogenic orthostatic hypotension
Evaluation of the current measurement strategy in neurogenic orthostatic hypotension
HTA assessment of therapeutic interventions and treatments for venous thromboembolism
Manuscript on the incidence of venous thromboembolism following major abdominal surgery
Abdominal surgery cohort study to evaluate the risk of venous thromboembolism
In-trial cost-consequences analysis of a drug used in venous thromboembolism
Matched cohort pulmonary embolism evaluation in orthopaedic surgery in Japan
Consulting on the Anticoagulant Treatment Satisfaction (ACTS) scale as an endpoint for FDA claims in venous thromboembolism and thromboembolism prophylaxis
Decentralised framework for real life data generation in venous thromboembolism
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsRead MoreACCEPTREJECT
Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
We’d like to set analytic software i.e. Google Analytics/Click Dimensions to help us improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone. For more information on how these cookies work, please see our Cookies Policy.